Today is Wear It Purple Day! To all my LGBTIQA+ friends, family, colleagues – I salute you! You have my support and admiration. It doesn’t matter where you are or what stage of being “out” you are at. You are amazing and loved. A special shout out to all our trans and gender diverse friends who are suffering from (continuing) worldwide discrimination and hate – I am Read More …
IP Australia have announced that they are hosting this event alongside the ChIPS ANZ Chapter for the first in-person event “Women in IP.” “ChIPs stands for “chiefs in intellectual property,” a key position in corporations overseeing issues surrounding patents, copyrights, trademarks and other areas of law central to innovation.”Professor Veena Sahajwalla, Inventor and Professor of Materials Science, Faculty of Science, University of New South Wales, Read More …
NSW Deputy Premier Troy Grant and Minister for Health Jillian Skinner launched the Medical Technology Knowledge Hub on 9 March 2015 at Baxter Healthcare’s campus at Old Toongabbie. The launch was attended by representatives of the Australian Medical Technology community. The Medical Technology Association of Australia is tasked with leading the MedTech Knowledge Hub which has been allocated $150,000 of funding from the NSW State Read More …
2014’s “Celebgate” (in which cloud computing accounts associated with mobile phones of various celebrities were hacked and posted online) has raised awareness of the problem of the posting of intimate photographs without the consent of the subject of the photographs. If you take a photograph of yourself, you own the copyright in it. This means that if you take a photograph of yourself doing something Read More …
It is not compulsory to use the ® and ™ symbols in Australia. However, as a trademark owner, you should use these symbols when your trade mark is used in social media posts (for example, Facebook posts, LinkedIn posts and even Twitter tweets – where possible). There are a number of reasons for doing this, but notably use of the ® and ™ symbols may Read More …
The Australian High Court has allowed Yvonne D’Arcy’s special leave application from the Full Federal Court decision in D’Arcy v Myriad Genetics Inc [2014] FCAFC 115. As a result, the patent claims directed to the gene BRCA1 (which has been found to exhibit particular mutations in women with an enhanced risk of developing breast and ovarian cancer) will be considered by the High Court sometime this year. Read More …
